- Etanercept - adherence to treatment, treatment retentiont; data from biologic registries2014 | Publication without faculty affiliation
- Etanercept - updatePublication without faculty affiliation
- mmunogenicity of TNF alpha inhibitors - focused on etanercept2015 | First Faculty of Medicine
- Etanercept, new dosage2007 | First Faculty of Medicine
- New knowledce about etanercept biological therapy of plaque psoriasis2009 | Faculty of Medicine in Hradec Králové
- New knowledce about etanercept biological therapy of plaque psoriasis2009 | First Faculty of Medicine
- Efficacy, safety and patient-reported outcomes of combination etanercept and sulfasalazine versus etanercept alone in patients with rheumatoid arthritis: a double-blind randomised 2-year study2009 | First Faculty of Medicine
- Editorial: Treatment of Wegerś Granulomatosis with etanercept, soluble TNF receptor2005 | First Faculty of Medicine
- Etanercept in therapy of rheumatoid arthritisPublication without faculty affiliation
- Etanercept2006 | First Faculty of Medicine
- Syndrom Gilliain-Barré in patient treated by etanercept2009 | First Faculty of Medicine
- Etanercept - ověřený lék pro revmatiky2006 | First Faculty of Medicine
- Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with moderate rheumatoid arthritis (PRESERVE): a randomised controlled trial2013 | First Faculty of Medicine
- Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis2018 | Faculty of Medicine in Pilsen
- Adalimumab in the treatment of pediatric psoriasis2016 | First Faculty of Medicine
- Juvenile generalized pustular psoriasis treated with etanercept2014 | Second Faculty of Medicine
- Terapie revmatoidní artritidy etanerceptem je účinnější u pacientů se střední než vysokou aktivitou nemoci2021 | First Faculty of Medicine, Central Library of Charles University
- Etanercept nebo metotrexát u pacientů s revmatoidní artritidou v trvalé remisi2021 | Third Faculty of Medicine
- Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial2015 | Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen, Third Faculty of Medicine
- Increased incidence of inflammatory bowel disease on etanercept in juvenile idiopathic arthritis regardless of concomitant methotrexate use2022 | First Faculty of Medicine
- Pharmacotherapy of psoriasis2006 | Second Faculty of Medicine
- Manifestation of Crohn's disease in a young woman during the course of treatment for severe form of chronic plaque psoriasis with etanercept2014 | Second Faculty of Medicine
- Bezpečnost etanerceptu u starších osob s revmatoidní artritidou: data z reálné klinické praxe2020 | Third Faculty of Medicine
- The difficult case of rheumatoid arthritis with extraarticular manifestations and multiple intolerance of therapy2012 | Faculty of Medicine in Hradec Králové
- Etanercept in moderate rheumatoid arthritis: PRESERVE study results from central/eastern Europe, Latin America and Asia2014 | First Faculty of Medicine
- The effect of adding etanercept to methotrexate and methotrexate to etanercept monotherapies on physical function and patient-reported outcomes in RA patients: tempo trial extension resultsPublication without faculty affiliation
- Maintenance of remission with combination etanercept-DMARD therapy versus DMARDs alone in active rheumatoid arthritis: results of an international treat-to-target study conducted in regions with limited biologic access2017 | First Faculty of Medicine
- Effect of etanercept therapy on psoriasis symptoms in patients from Latin America, Central Europe, and Asia: a subset analysis of the PRISTINE trial2015 | Faculty of Medicine in Pilsen
- Biological therapy in Rheumatology2016 | First Faculty of Medicine
- Double-blind comparison of etanercept and sulfasalazine, alone and combined in aktive RA patientsPublication without faculty affiliation